Longevity & Anti-Aging
Longevity and anti-aging claims checked against human studies: supplements, drugs, biological age tests and habits said to slow aging. Each article says what the trials found, how strong the evidence is and where it stops.
-
An organ age test scores each organ from one blood draw. What 43,616 adults show about brain aging, early death, and why the number is not yet personal.
-
No dog longevity drug is approved yet. LOY-002 has cleared two of three FDA sections, and the 1,300-dog trial testing whether it works has not reported.
-
The blue zones’ habits hold up, but the head counts do not: US birth certificates cut records of people past 110 by 69 to 82 percent. Here is the evidence.
-
Klotho longevity shots sell for about $25,000 abroad. One low dose helped aged monkeys remember, but no human trial has yet shown a real benefit in people.
-
Not yet. NAD IV therapy has never been tested for the benefits clinics sell it for, and one session costs $200 to over $1,000. What 113 NAD+ studies show.
-
Plasma exchange longevity claims rest on one 42-person trial where a biological age score fell 2.6 years. No strength, memory or illness was measured.
-
An audit ran the same 16 epigenetic clocks across 51 human trials. Only 19 interventions did anything to slow biological aging, and few were supplements.
-
Menopause hormone therapy relieves hot flushes and protects bone, but it is not a prevention drug. What 20 years of Women’s Health Initiative data show.
-
The biggest trial of testosterone therapy risks found no extra heart attacks, but more irregular heartbeats, lung clots and broken bones. The full picture.
-
Not very, for one person. Run one blood sample twice and a biological age test can shift by up to 9 years. What the number can and cannot tell you.
